AAAAAA

   
Results: 1-25 | 26-47 |
Results: 26-47/47

Authors: von Moltke, LL Greenblatt, DJ Granda, BW Grassi, JM Schmider, J Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions, PSYCHOPHAR, 145(1), 1999, pp. 113-122

Authors: Fogelman, SM Schmider, J Venkatakrishnan, K von Moltke, LL Harmatz, JS Shader, RI Greenblatt, DJ
Citation: Sm. Fogelman et al., O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: Effect of metabolic inhibitors and SSRI antidepressants, NEUROPSYCH, 20(5), 1999, pp. 480-490

Authors: Schmider, J Von Moltke, LL Shader, RI Harmatz, JS Greenblatt, DJ
Citation: J. Schmider et al., Extrapolating in vitro data on drug metabolism to in vivo pharmacokinetics: Evaluation of the pharmacokinetic interaction between amitriptyline and fluoxetine, DRUG METAB, 31(2), 1999, pp. 545-600

Authors: von Moltke, LL Greenblatt, DJ Granda, BW Duan, SX Grassi, JM Venkatakrishnan, K Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations, BR J CL PH, 48(1), 1999, pp. 89-97

Authors: Greenblatt, DJ von Moltke, LL Hermatz, JS Shader, RI
Citation: Dj. Greenblatt et al., Human cytochromes mediating sertraline biotransformation: Seeking attribution, J CL PSYCH, 19(6), 1999, pp. 489-493

Authors: Greenblatt, DJ Von Moltke, LL Harmatz, JS Shader, RI
Citation: Dj. Greenblatt et al., Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions, J CL PSYCH, 19(5), 1999, pp. 23S-35S

Authors: Greenblatt, DJ von Moltke, LL Daily, JP Harmatz, JS Shader, RI
Citation: Dj. Greenblatt et al., Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: The clinical dilemma of concurrent inhibition and induction, J CL PSYCH, 19(4), 1999, pp. 293-296

Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, More on potassium, the heart, and antipsychotic agents, J CL PSYCH, 19(3), 1999, pp. 201-202

Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, The reappearance of a monoamine oxidase inhibitor (isocarboxazid), J CL PSYCH, 19(2), 1999, pp. 105-106

Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, Potassium, antipsychotic agents, arrhythmias, and sudden death (vol 18, pg427, 1998), J CL PSYCH, 19(2), 1999, pp. 106-106

Authors: Greenblatt, DJ Shader, RI
Citation: Dj. Greenblatt et Ri. Shader, Mass units or molar units for drug concentration?, J CL PSYCH, 19(1), 1999, pp. 1-2

Authors: Fahey, JM Pritchard, GA Grassi, JM Pratt, JS Shader, RI Greenblatt, DJ
Citation: Jm. Fahey et al., In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration, J PSYCHOPH, 13(3), 1999, pp. 211-218

Authors: Shader, RI Granda, BW von Moltke, LL Giancarlo, GM Greenblatt, DJ
Citation: Ri. Shader et al., Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast, BIOPHARM DR, 20(8), 1999, pp. 385-388

Authors: Fahey, JM Pritchard, GA Pratt, JS Shader, RI Greenblatt, DJ
Citation: Jm. Fahey et al., Lorazepam attenuates the behavioral effects of dizocilpine, PHARM BIO B, 62(1), 1999, pp. 103-110

Authors: Shader, RI Harmatz, JS Oesterheld, JR Parmelee, DX Sallee, FR Greenblatt, DJ
Citation: Ri. Shader et al., Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder, J CLIN PHAR, 39(8), 1999, pp. 775-785

Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Venkatakrishnan, K Duan, SX Fogelman, SM Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects, BIOL PSYCHI, 46(6), 1999, pp. 839-849

Authors: Chuck, SK Rodvold, KA Von Moltke, LL Greenblatt, DJ Shader, RI
Citation: Sk. Chuck et al., Pharmacokinetics of protease inhibitors and drug interactions with psychoactive drugs, AIDS PREV M, 1999, pp. 33-60

Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Fogelman, SM Harmatz, JS Kramer, SJ Fabre, LF Shader, RI
Citation: Ll. Von Moltke et al., Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects, PSYCHOPHAR, 140(3), 1998, pp. 293-299

Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, Potassium, antipsychotic agents, arrhythmias, and sudden death, J CL PSYCH, 18(6), 1998, pp. 427-428

Authors: Von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Venkatakrishnan, K Schmider, J Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A, J PHARM PHA, 50(9), 1998, pp. 997-1004

Authors: Venkatakrishnan, K Von Moltke, LL Duan, SX Fleishaker, JC Shader, RI Greenblatt, DJ
Citation: K. Venkatakrishnan et al., Kinetic characterization and identification of the enzymes responsible forthe hepatic biotransformation of adinazolam and N-desmethyladinazolam in man, J PHARM PHA, 50(3), 1998, pp. 265-274

Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Mertzanis, P Graf, JA Durol, ALB Counihan, M Roth-Schechter, B Shader, RI
Citation: Dj. Greenblatt et al., Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole, CLIN PHARM, 64(6), 1998, pp. 661-671
Risultati: 1-25 | 26-47 |